kruptcy enabled Evident to resolve a lawsuit with California-based Invitrogen Corp. Now, Evident is nearing commercialization of a new product in the field of thermoelectrics that will lead to hiring later this year, CEO Clint Ballinger said to Business Review in Albany. SOLA Ltd., a U.S. hedge fund, owns 73% of Evident.
Adam Sichko: Evident clears bankruptcy court; $75K/ month fed grant in works, In: The Business Review (Albany), April 9, 2010: ht tp: / / a lbany .bi z journa l s . com/ a lbany / s to-
ries/2010/04/12/story6.html?b=1271044800%5E3160151 &ana=e_vert http://www.evidenttech.com
resco Microchip Inc., a fabless semiconductor company focused on leading edge RF, mixed-
signal and digital signal processing integrated circuits (ICs), has shipped more than five million receivers for the global hybrid (analog + digital) television market. The company’s exponential sales ramp demonstrates that Fresco Microchip’s game chan- ging technology, which offers unprecedented picture quality and lower system costs, has transformed the TV receiver industry by delivering value through innovation.
federal judge has cleared Evident Technologies Inc. to emerge from bankruptcy. The ban-
principal analyst at In-Stat. “Hybrid-ready tuners represent over 70% of all TV tuners projected for 2010.”
In January 2010, Fresco announced that the compa- ny had shipped more than one million units. In just two months, shipments have increased five-fold and Fresco anticipates strong growth to continue in next months. Seven of the top nine tuner manufacturers, who account for nearly 70% of all tuners sold today, are in production or designing products using Fresco inside. Fresco has set the de-facto industry standard for superior broadcast quality at the lowest system cost.
The Company closed a financing round totaling $10
million in October 2009. Celtic House Venture Part-
ners and Ventures West led the financing round. Fresco will expand its commercial activities and bring new products to market with the funding.
luidigm Corporation and SABiosciences (a QIAGEN Company) have teamed up to create
over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System for Genetic Analysis. These kits are named the RT² Profiler™ PCR Arrays for the Fluidigm BioMark system.
“Fresco’s technology has created a fundamental paradigm shift in the industry and the company is emerging as a top supplier for global hybrid recei- vers, particularly in Europe,” said Gerry Kaufhold,
These gene expression assays are specifically desi- gned for the workflow of Fluidigm‘s integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers needed for synthesizing first-strand cDNA ready for preamplification and pathway-focused analysis. PCR Arrays contain enough reagent to run five 96.96
10-04 :: April 2010